Long-term APBI Cosmetic, Toxicity Data Reported medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Search
Nucleus Commercial Finance Reports that More UK Residents are Supporting SMBs during COVID but Say Quality Is Better when Buying from Major Retailers
December 15, 2020 @ 11:50 pm By Omar Faridi
More UK-based consumers have been supporting their local independent businesses during the COVID-19 pandemic, according to research conducted by
Nucleus Commercial Finance.
The researchers revealed that the vast majority (96%) of UK consumers support their local businesses and 63% of them have made a special effort to do so since awareness about the Coronavirus pandemic began to spread in early February and March of this year.
Over 70% of consumers responding to the survey said they plan to spend more with their local businesses than they did in previous years. Nearly 80% of London-based consumers claimed that they will buy more items from small independent businesses following the COVID-19 outbreak.
Share this article
Share this article
LAGUNA HILLS, Calif., Dec. 15, 2020 /PRNewswire/ Prelude Corporation (PreludeDxä), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented clinical outcomes data last week at the San Antonio Breast Cancer Symposium (SABCS) that further validates the DCISionRT® test results of an independent study by Kaiser Permanente Northwest published earlier this year in
Clinical Cancer Research. DCISionRT is a biologic risk signature that assess the 10-yr risk of a subsequent breast cancer recurrence. A Spotlight Poster presented at SABCS, showed that the DCISionRT test reclassified 45% of patients meeting RTOG 9804 low risk or good risk criteria for Ductal Carcinoma In Situ (DCIS) as Decision Score (DS) Elevated Risk. These patients who were reclassified by the DCISionRT test to DS Elevated Risk had clinically elevated 10-year breast cancer rates when treated without radiation therapy (RT) and demons